Simmons Jeffrey N's Form 4 filing
Elanco Animal Health Inc (ELAN) · filed Aug 11, 2021
- Accession no.
- 0000950138-21-000410
- Filed
- Aug 11, 2021
- Trade date
- Aug 11, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $500.4K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simmons Jeffrey NCIK 0001479079 | Director, Officer (President, CEO & Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2021 | Common Stock | PPurchaseAcquired | +16,850 | $29.70F1 | +$500,445 | 568,577 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were purchased in multiple transactions, all at the price of $29.70.
Referenced by the price of 1 transaction in Table I.